Variability in hospital costs of adult spinal deformity care by Jacobs, Karel et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/spinejournalby
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3e0Y
qcP
6sdeyyR
D
prP
B
bE
5M
W
5N
c70Y
TFQ
8W
43vTIS
5B
o=
on
09/13/2020
Downloadedfromhttps://journals.lww.com/spinejournalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3e0YqcP6sdeyyRDprPBbE5MW5Nc70YTFQ8W43vTIS5Bo=on09/13/2020
 Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Variability in Hospital Costs of Adult Spinal
Deformity Care
Karel Jacobs, MSc,a,b,c,d Thibault Dewilde, MD,a,c Cindy Vandoren, MSc,a Brecht Cardoen, PhD,d,e
Nancy Vansteenkiste, MSc,a Lennart Scheys, PhD,a,c Filip Roodhooft, PhD,f,g
Lieven Moke, PhD,a,c and Katrien Kesteloot, PhDa,b
Study Design. Retrospective, single-center analysis.
Objective. To calculate the total clinical hospital cost of the
Adult Spinal Deformity (ASD) care trajectory, to explain cost
variability by patient and surgery characteristics, and to identify
areas of process improvement opportunities.
Summary of Background Data. ASD is associated with a
high financial and clinical burden on society. ASD care thus
requires improved insights in costs and its drivers as a critical
step toward the improvement of value, i.e., the ratio between
delivered health outcome and associated costs.
Methods. Patient characteristics and surgical variables were
collected following ethical approval in a cohort of 139 ASD
patients, treated between December, 2014 and January, 2018.
Clinical hospital costs were calculated, including all care
activities, from initial consultation to 1 year after initial surgery
(excl. overhead) in a university hospital setting. Multiple linear
regression analysis was performed to analyze the impact of
patient and surgical characteristics on clinical costs.
Results. 75.5% of the total clinical hospital cost (s27,865) was
incurred during initial surgery with costs related to the operating
theatre (80.3%), nursing units (11.9%), and intensive care (2.9%)
being the largest contributors. 57.5% of the variation in total
cost could be explained in order of importance by surgical
invasiveness, age, coronary disease, single or multiple-staged
surgery, and mobility status. Revision surgery, unplanned surgery
due to complications, was found to increase average costs by
87.6% compared with elective surgeries (s 44,907 ( s 23,429)
vs. s 23,944 ( s 7302)).
Conclusion. This study identified opportunities for process
improvement by calculating the total clinical hospital costs. In
addition, it identified patient and treatment characteristics that
predict 57.5% of cost variation, which could be taken into
account when developing a payment system. Future research
should include outcome data to assess variation in value.
Key words: adult spinal deformity, ASD-surgical invasiveness
score, cost drivers, costs, value-based healthcare, variation in
costs.
Level of Evidence: 4
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H
ealthcare providers, working with limited health-
care budgets, attempt to achieve better clinical
outcomes at lower costs of care and thus, maxi-
mize the value in healthcare.1 Particularly in chronic dis-
orders, such as Adult Spinal Deformity (ASD),2
characterized by a lifelong outcome and cost impact, value
improvements are potentially beneficial, for both society,
patients, and care providers.
Accurate cost data are essential in the search for process
improvement.3 Similar to other diseases,3 ‘‘costs’’ in ASD
literature are based on reimbursement data4–7 and/or the
scope is limited to the index surgery.4,5,8 Instead, costs
ideally reflect the monetary value of the largest possible
part of all resources used during the entire patient’s care
trajectory,9 rather than the peculiarities of different
reimbursement systems.
Furthermore, in many countries, innovative reimburse-
ment systems are developed in an attempt to control increas-
ing healthcare costs. Bundled payments10,11 are one such
attempt. Hereby, a fixed amount is reimbursed for all
providers in the care trajectory for a certain patient group,
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during a certain period of time. It aims to promote clinical
continuity and to align incentives for care providers
around value instead of volume.12 An important challenge
in introducing bundled payments is the differences in ‘‘jus-
tified care’’13 for different subgroups. There is, for instance,
risk of patient cherry-picking (e.g., patients without comor-
bidities or favorable surgical episodes) when the bundled
payment would not take these factors into account.
Data on true costs, including its variability drivers, are
needed to implement a bundled payment system that
encourages to provide the right care, without inducing
adverse selection.
Accordingly, this paper aims to identify the drivers of the
total clinical hospital costs of the ASD care trajectory in an
academic referral center. We hypothesize 1) that we can
explain cost variability by patient and surgical character-
istics, needed to move from fee for service to bundled pay-
ments and 2) that we will be able to identify areas of process
improvement opportunities in the care pathway.
MATERIALS AND METHODS
This study was approved by the KULeuven ethical commit-
tee (S61657) and took place at University Hospitals Leuven.
One hundred thirty-nine ASD patients met the inclusion
criteria and were enrolled in the current study. Patients with
lumbar spondylolisthesis, adolescent idiopathic scoliosis,
Scheuermann kyphosis, neuromuscular (kyfo-)scoliosis, de
novo degenerative scoliosis, and (iatrogenic) flat back defor-
mity were included. Initial (¼index) surgery was performed
between December 2014 and January 2018. The study
population was divided into two subgroups, depending
on the number and nature of surgical episodes during the
1-year follow-up period. The first subgroup entailed all
patients with one (n¼92) or several (n¼22) planned sur-
geries (Gr1_planned). The second subgroup entailed
patients with at least one revision surgery due to compli-
cations (n¼25) (Gr2_revision). Both clinical and cost data
were collected for all patients.
Clinical Data
Clinical data were collected retrospectively between August
and December 2018 via electronic patient record analyses
on demographics, comorbidities, and surgical characteris-
tics (see Table 1). Next to the American Society of Anes-
thesiologists -score, the five-item modified frailty index (5i-
mFI)14 was calculated to score the patient’s physiological
status based on the presence of diabetes mellitus, congestive
heart failure, hypertension requiring medication, history
of COPD, and a partially dependent functional status.
The 5i-mFI has been demonstrated to correlate with the
length of stay (LOS), readmission, and complications14 and
could thus affect costs. In addition, the ASD surgical inva-
siveness score15 (ASD-S) was calculated.15 Vertebral column
resection was scored in the same way as a three-column
osteotomy. For every patient, a second ASD-S score was
determined, adding up all ASD-S scores of the individual
surgical episodes, further referred to as the ‘‘ASD-Scombined.’’
Finally, patients’ primary diagnoses were labeled using The
Spine Tango16 diagnostic classification.
Cost Data
The clinical cost of the care trajectory analyzed in our study
equals the sum of the different costs of all in- and outpatient
pre-, peri-, and postoperative services, provided within the
university hospital. Both direct and indirect costs of clinical
care within the hospital are included.
Medication and implants were registered per patient and
are therefore direct costs, directly attributed to the patients.
Other clinical hospital costs were allocated on the basis of
the classic two-stage ABC-allocation principle,17 using the
data of the hospital’s own Activity Centre—Care program18
model. This model permits calculating the costs of the care
trajectory within the hospital by taking the different activi-
ties and their frequency per patient into account. First, costs
of each resource (e.g., nurses, utilities, equipment) are
allocated by a resource cost driver to activity centers, which
are functional units where each of the activities is per-
formed, such as the operating room, the lab, the ward,
etc. Next, the activity cost pool at the level of the activity
centers is allocated to patient groups through activity cost
drivers, such as the number of X-rays, the operating time,
the length of stay.
Costs of supporting services such as administration,
cleaning services, or the human resources department are
not included in the present analysis because of the limited
effect of ASD patients on the total overhead costs. This
approach implies that the cost data are mainly suitable to
identify and assess cost differences between patient groups
or different care approaches—and cannot be used to set
‘‘full’’ reimbursement rates (although the data could be used
to differentiate reimbursement rates between subgroups of
patients).
This total clinical cost of the hospital care trajectory will
be further referred to as the total cost per patient, although it
should be kept in mind that this ‘‘total’’ cost does not include
overhead costs.
Statistics
Statistical analyses were carried out using SPSS software
(v. 25.0.0; SPSS Inc, Chicago, IL). Descriptive statistics
including means and standard deviations were performed
on patient and surgery characteristics, as well as on
costs. Independent t tests were performed to assess the
differences in patient and treatment characteristics between
GR1_planned and GR2_revision. In addition, bivariate
linear correlation analyses were used to assess the level of
correlation between patient and treatment characteristics on
the one hand and the total cost per patient on the other hand.
Means and variation of the total cost per patient were
calculated and compared between subgroups. The nonpara-
metric Mann–Whitney U and Kruskall–Wallis test, com-
bined with posthoc tests if needed, were performed, to
examine the link between the independent categorical var-
iables and the dependent right-skewed variable of the total
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cost per patient. Finally, a multiple linear regression
model was used to explain the total cost per patient, the
costs of the three phases (preparation, initial intervention,
and follow-up phase), and the cost of initial surgery.
Logarithmic (natural base) transformations were performed
for follow-up costs and total cost per patient to deal
with their skewed distribution. For all analyses, the level
of significance was set at 0.05 and assumptions were vali-
dated.
RESULTS
Patient and Surgery Characteristics
One hundred thirty-nine ASD patients were included in this
study. 67.6% were female and 24.5% were smoking. The
BMI ranged from 16.1 kg/m2 to 40.1 kg/m2 with 25.6 kg/m2
as average. 18.0% of patients were walking with a device,
3.6% were wheelchair-bound, whereas 78.4% could walk
independently. 16.5% were living partially dependent (with
TABLE 1. Patient and Surgery Characteristics
Characteristic
All Included
Patients
(n¼139)
P (Sign.
Correlation
With Total Cost)
Statistic
Gr1_planned
(n¼114)
Gr2_
revision
(n¼25)
P (Sign. Differ-
ence Between
Subgroups)
Demographics
Mean age in years (SD) 55.4 (17.2) 0.015§ 54.0 (17.5) 61.4 (14.4) 0.046§
Female (%) 94 (67.6%) 0.675 78 (69.0%) 16 (61.5%) 0.462
Mean body mass index (SD) 25.6 (4.7) 0.050 25.2 (4.4) 27.3 (5.5) 0.045§
Mobility status 0.024§ 0.301
Walking independently (%) 109 (78.4%) 0.012§ 91 (80.5%) 18 (69.2%)
Walking with device (%) 25 (18.0%) 0.075 18 (15.9%) 7 (26.9%)
Wheelchair bound (%) 5 (3.6%) 0.057 4 (3.5%) 1 (3.9%)
Functional status 0.003§ 0.314
Living independently 110 (79.1%) 0.001§ 92 (81.4%) 18 (69.2%)
Living partially dependently 23 (16.5%) 0.010§ 16 (14.2%) 7 (26.9%)
Living dependently 6 (4.3%) 0.054 5 (4.4%) 1 (3.8%)
Smoking (%) 34 (24.5%) 0.360 27 (23.9%) 7 (26.9%) 0.746
Primary diagnosis
Degenerative deformity 91 (65.5%) 0.000§ 70 (62.0%) 21 (80.8%) 0.076
Nondegenerative deformity 26 (18.7%) 0.130 25 (22.1%) 1 (3.9%) 0.061
Foraminal stenosis 7 (5.0%) 0.885 6 (5.3%) 1 (3.9%) 0.759
Central stenosis 6 (4.3%) 0.014§ 5 (4.4%) 1 (3.9%) 0.896
Others 9 (6.5%) 0.002§ 7 (6.2%) 2 (7.7%) 0.780
Comorbidities
Arterial hypertension 36 (25.9%) 0.711 27 (23.9%) 9 (34.6%) 0.264
Mitral valve prolapse 22 (15.8%) 0.350 19 (16.8%) 3 (11.5%) 0.509
Osteoporosis 20 (14.4%) 0.976 17 (15.0%) 3 (11.5%) 0.647
Spinal cord injury 17 (12.2%) 0.219 12 (10.6%) 5 (19.2%) 0.234
Depression 10 (7.2%) 0.839 7 (6.2%) 3 (11.5%) 0.349
Modified Frailty indexy 0.039§ 0.039§
Nonfrail 76 (54.7%) 66 (58.4%) 10 (38.5%)
Frail 45 (32.4%) 35 (31.0%) 10 (3.5%) 0.096
Severely frail 18 (13.0%) 12 (10.6%) 6 (23.1%)
Surgery characteristics
ASD-S score (SD) 32.7 ( 12.5) <0.001§ 33.5 (13.0) 29.3 (10.0) 0.128
ASD-Scombined (SD) 37.2 (15.7) <0.001§ 36.0 (15.2) 42.6 (16.6) 0.061
LOS initial hospitalization (SD) 11.8 (9.1) <0.001§ 10.4 (4.1) 18.0 (18.4) 0.02§
Combined LOS care trajectoryz (SD) 19.0 (23.1) <0.001§ 13.4 (10.8) 43.1 (41.1) <0.01§
Numbers are rounded to the first decimal place.
Comorbidities with less than five observations such as Parkinson, cerebral palsy, congestive heart failure, etc., were not visualized and excluded from further statistics.
yModified frailty index: frailty was scored on five items including diabetes mellitus, congestive heart failure, hypertension requiring medication, history of
COPD, and functional status: partially dependent. The authors categorized patients with 0, 1, and 2 or more on a scale of 5 as resp. ‘‘non-frail,’’ ‘‘frail,’’ and
‘‘severely frail,’’ respectively.
zCombined LOS of all hospital admissions during the care trajectory.
§Significantly different (P < 0.05).
SD indicates standard deviation, LOS, length of stay.
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the help from a nurse or a relative), 4.3% were living
completely dependent (e.g., in a retirement home), 79.1%
lived independently. 96.4% of all patients had at least one
comorbidity. Most common comorbidities were arterial
hypertension (25.9%), mitral valve prolapse (15.8%), oste-
oporosis (14.4%), spinal cord injury (12.2%), and depres-
sion (7.2%). The most common primary diagnoses were
degenerative deformity (65.5%) and nondegenerative defor-
mity (18.7%), followed by foraminal stenosis (5.0%) and
central stenosis (4.3%). Independent t tests revealed signifi-
cant differences between Gr1_planned and Gr2_revision in
age, BMI, and modified frailty-index.
The ASD-S of the initial surgical episode was 32.7 (range
7–77). The mean ASD-Scombined was 37.2 (range 7–144).
The average LOS of the initial surgical episode was
11.89.1 days and the average combined LOS of
all hospital stays during the defined care trajectory
was 18.923.1 days. Independent t tests revealed signifi-
cant differences between Gr1_planned and Gr2_revision
in LOS of the initial hospitalization and the combined
LOS. Table 1 gives a detailed overview of all patient
and surgery characteristics, both overall and on
subgroup level.
Costs
The average total cost per patient of the entire 1-year care
trajectory wass 27,865 (n¼139) with a standard deviation
of s 14,493. On average, the largest part of these costs is
incurred during the initial intervention and hospital stay
(75.5%). 21.3% of costs were incurred during the follow-up
phase, 3.2% was incurred during the preparation phase
(Figure 1). During the initial intervention and hospital stay,
the bulk of costs was incurred in the operating theater
(80.3%) with the most important cost categories being
implants (32.9%), other materials (16.1%), medical and
nonmedical staff (resp. 13.9% and 12.1%). A breakdown of
initial intervention costs is found in Figure 2.
As summarized in Table 1, age, BMI, mobility status,
functional status, degenerative deformity, central stenosis,
other diagnosis, modified frailty index, ASD-S, ASD-Scombined,
and length of stay, were all significantly related to the total cost
per patient.
As shown in Figure 3, revision surgery (Gr2_revision)
was found to increase costs by 87.6% compared with
elective surgery (Gr1_planned), with average costs of resp.
s 44,907 and s 23,944. This increase was additionally
associated with an increased standard deviation of resp.s
All included patients (n=139) Gr1_planned (n=114) Gr2_revision (n=25)
Preparation phase 3.2% € 891 4.0% € 947 1.8% € 788
Initial intervention 75.5% € 21,038 86.9% € 20,807 53.8% € 24,150
Follow-up 21.3% € 5,935 9.2% € 2,191 44.5% € 19,970
€ 27,865 € 23,945 € 44,908
Figure 1. The relative contribution of the different phases to the total cost per patient for all patients, Gr1_planned and Gr2_revision.
Operating theatre 80.3 % € 16,894
Implants 32.9 %
Other materials 16.1 %
Medical staff 13.9 %
Non-medical staff 12.1 %
Drugs 2.8 %
Equipment (depreciation) 2.4 %
Ward 11.9 % € 2,504
Lab 3.6 % € 757
ICU 2.9 % € 610
Rest 1.3 % € 273
€ 21,038
Figure 2. Relative contribution to the cost of the initial intervention and hospital stay.
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23,429, compared withs 7302. The follow-up phase
showed the largest significant difference (P value <0.001)
in costs between Gr2_revision (s 19,969) and Gr1_planned
(s 2191).
Figure 4 shows the average cost per phase with standard
deviation for all patients and for the subgroups separately.
The quartile coefficient of dispersion shows that the initial
intervention, overall and for each subgroup, has the least
relative variation. In contrast, the cost of the follow-up
phase is characterized by a large variation.
Table 2 summarizes the different stepwise linear regres-
sion models, including regression coefficients, P values, and
R2. Variation in total cost per patient could be explained, in
order of importance, by the ASD-Scombined, age, coronary
disease, multiple versus single planned surgery, and mobility
status. Together, these variables explain 57.5% of variation.
43.0% of the variation in initial surgery cost could be
explained by the ASD-S and American Society of Anesthesi-
ologists score only.
DISCUSSION
The purpose of this study was to calculate the total cost per
patient of the ASD (1-year) care trajectory and examine its
variability at an academic referral center, to identify the cost
of the different phases of the hospital care trajectory and to
investigate causes of cost variations between subgroups
of patients.
Overall, the initial surgery accounted for 75.5% of the
total clinical hospital cost, which is in line with recent
literature.19 A large proportion (80.3%) of these costs
was incurred in the operating theater, which makes the
surgery the primary focus for value improvement for this
population. As such, ASD-S is a good candidate to support
more precise planning of surgery time slots and adjust the
standard average times that are currently in place at our
hospital. Indeed, this study showed that the ASD-S predicts
almost half of the variation in surgery time. 88.5% of index
surgeries had at least 30 minutes overtime, with 64.7% of
surgeries exceeding 2 hours of overtime, resulting in
410 hours of total overtime. In addition, 4.3% of surgeries
were at least 30 minutes shorter than originally planned.
ASD-S-based surgery time allocation is thus expected to be
more in line with reality and thus allow better use of excess
capacity or avoiding over time resulting in a lower capacity
cost rate.
Thirdly, surgeons and management could use these data
to decide on investments in techniques or changes in the
work flow, which reduce surgery time. Because our model
includes all activities over the care cycle period, it will be
possible to check how such changes in work flow, or new
techniques are beneficial over the entire care trajectory (e.g.,
can the introduction of a team briefing pre and postsurgery
(thereby increasing staff time) reduce the operating time
(thereby reducing—more expensive—OT staff time?)).
At University Hospitals Leuven, surgeons currently plan
preoperative examinations according to the presented
comorbidities of the patient. Therefore, it was expected
that variability in the costs of the preoperative phase could
be predicted, based on the presented comorbidities. How-
ever, this was not reflected in our data. More in-depth
analyses showed that the preoperative preparation was
not as standardized as presumed. Therefore, our data sug-
gest an opportunity for adopting a more standardized evi-
dence-based workflow of preoperative examinations and
corresponding actions depending on the comorbidities of
the patient, following the guidelines20 of the Belgian Health
Care Knowledge Centre.
Evidently, we strive to avoid revision surgery due to
complications, both for quality and cost reasons. Indeed,
this study illustrates that revision surgery due to complica-
tions (infection, material failure, and neuro-compression)
significantly increases costs (total cost per patient of s
44,907 instead of s 23,429). These insights can help to
decide on investment strategies. Theoretically, investing in a
technique that costs s 2262 per patient, bringing down
revision surgery due to complications by 50% from 22.0%
to 11.0% would be breakeven (i.e., no extra cost) and thus,
be justifiable, from an economic point of view (due to better
outcomes, i.e., less complications).
The second aim of this study was to identify drivers of the
variability in the total clinical hospital costs. As a recent
study concluded,11 accounting for payment variation would
be the greatest challenge in spine surgery when moving to
bundled payments. ASD-Scombined, age, coronary disease,
one or multiple planned surgeries, and mobility status were
all found to affect the total cost per patient. Therefore, these
20
Total cost per patient ( € 000)
0 40 60 80 100
Gr1_planned
Gr2_revision
120
x
x
Figure 3. Boxplot comparing total clinical hospital costs (s 1000 s) between Gr1_planned and Gr2_revision. The white line within each box
represents the mean, the X represents the average. The whiskers extend to the most extreme data point within the range of 1.5  IQR from
the box. Outliers, data points outside the range of the whiskers are shown as dots.
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factors should be included in a risk-adjusted bundled pay-
ment system, as seen in other payment models in spine
surgery.12,21
The results of this study must be interpreted within the
context of its design. First, the clinical data were gathered
retrospectively and are susceptible to registration bias. If a
certain comorbidity was not documented in the patient
record due to incomplete registration, it was incorrectly
assumed that this patient did not have that comorbidity.
Second, cost analyses were performed only at a tertiary
academic center. Costs of care provided outside the hospital,
for example, GP consultations, home medication, or ambu-
latory physiotherapy services were not included because of a
lack of data on these activities within the current study
design. Third, only care-related hospitals costs were taken
into account. Overhead hospital costs were excluded
because adding these costs would not add additional insights
into true reasons for variation in the cost data. Furthermore,
these costs are not expected to be affected when improving
care delivery.
In conclusion, this study identified the total cost of care
over the full 1-year hospital cycle and its composition,
together with areas of process improvement opportunities.
It also identified variability drivers to the total cost of care,
needed for bundled payments. Further research should focus
on including costs incurred outside the hospital and on
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separately.
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outcome data, to assess changes in value and to move
toward outcome-based bundled payments. This cost study
was a first step in the shift from outcome to value-driven
healthcare for the ASD population.
Key Points
The total clinical hospital cost of the 1-year
intrahospital ASD surgical care trajectory is s
27,865 ( s14,493) per patient.
Patient characteristics, such as age, coronary
disease, and preoperative mobility status,
together with surgery characteristics such as the
surgical invasiveness index and single versus
multiple staged surgery are significant cost
predictors in the 1-year intrahospital ASD
surgical care pathway.
Revision surgery due to complications is a
major driver of the total clinical hospital cost,
increasing costs by 87.6% compared with elective
surgery.
TABLE 2. Stepwise Regression Models
Total Clinical Hospital Cost Coefficient (b) P Value R2
Intercept 4921 <0.001 0.575
Surgical invasiveness score combined 0.014 p <0.001
Age 0.004 0.002
Coronary disease 0.500 0.001
Multiple planned surgeries 0.209 0.001
Mobility status
Walking with device 0.141 0.023
Wheelchair-bound 0.259 0.045
Cost preparation phasey Coefficient (b, euros) P value R2
Intercept 891 <0.001 0.055
Functional status
Living dependently 589 0.005
Cost initial hospitalisationy Coefficient (b, euros) P value R2
Intercept 10,286 <0.001 0.474
Surgical invasiveness score 295 <0.001
Mobility status
Walking with device 4004 0.001
Wheelchair-bound 14,037 <0.001
Carotid artery disease 6419 0.002
Cerebral palsy 10,423 0.003
Previous blood clot z 4621 0.049
Cost follow-up Coefficient (b) P value R2
Intercept 4024 <0.001 0.335
Surgical invasiveness score combined 0.040 n <0.0011
Coronary disease 2.240 0.004
Age 0.020 0.006
Diabetes mellitus 1.181 0.014
Other neurological disorders 0.676 0.017
Cost initial surgeryy (operating theater) Coefficient (b, euros) P value R2
Intercept 8897 <0.001 0.430
Surgical invasiveness score 240 <0.001
ASA score of 3 1445 <0.029
We used a logarithmic transformation for dependent variables with a skewed distribution: logYi¼aþbXi þei: Each 1-unit increase in X multiplies the expected
value of Y by eb.
yWe used a general linear model for dependent variables that were normally distributed: Yi¼aþbXi þei : Each 1-unit increase in X increases the expected
value of Y by b.
zIncludes deep vein thrombosis, pulmonary embolism.
SD indicates standard deviation, LOS, length of stay.
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